Charles River Laboratories International, Inc. (CRL): Revenue
$4.02B
Year ended 2025-12-27
$4.00B
Trailing 12 months to 2026-06-27
+0.3%
3-year compound annual growth
+6.5%
5-year compound annual growth
+11.4%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-27 | $4.02B | -0.9% | 2026-02-18, From 2024-12-29 |
| 2024-12-28 | $4.05B | -1.9% | 2026-02-18, From 2023-12-31 |
| 2023-12-30 | $4.13B | +3.9% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | $3.98B | +12.3% | 2025-02-19, From 2021-12-26 |
| 2021-12-25 | $3.54B | +21.1% | 2024-02-14, From 2020-12-27 |
| 2020-12-26 | $2.92B | +11.5% | 2023-02-22, From 2019-12-29 |
| 2019-12-28 | $2.62B | +15.7% | 2022-02-16, From 2018-12-30 |
| 2018-12-29 | $2.27B | +22.0% | 2021-02-17, From 2017-12-31 |
| 2017-12-30 | $1.86B | +10.5% | 2020-02-11, From 2017-01-01 |
| 2016-12-31 | $1.68B | +23.3% | 2019-02-13, From 2015-12-27 |
| 2015-12-26 | $1.36B | +5.1% | 2018-02-13, From 2014-12-28 |
| 2014-12-27 | $1.30B | +11.3% | 2017-02-14, From 2013-12-29 |
| 2013-12-28 | $1.17B | +3.2% | 2016-02-12, From 2012-12-30 |
| 2012-12-29 | $1.13B | -1.1% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $1.14B | +0.8% | 2014-02-25, From 2010-12-26 |
| 2010-12-25 | $1.13B | -3.3% | 2013-02-27, From 2009-12-27 |
| 2009-12-26 | $1.17B | -9.5% | 2012-02-27, From 2008-12-28 |
| 2008-12-27 | $1.30B | n/a | 2011-02-23, From 2007-12-30 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $4.02B | -0.9% |
| Incyte Corp (INCY) | 2025-12-31 | $5.14B | +21.2% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $2.53B | +20.0% |
| Icon PLC (ICLR) | 2025-12-31 | $8.25B | +0.8% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $16.31B | +5.9% |
| NRC Health (NRC) | 2025-12-31 | $137.39M | -4.0% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $33.03M | -14.5% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $18.67M | -29.3% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $16.37M | +304.0% |
Compare CRL, INCY, MEDP, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗